Fake versions of the medication have been traced to Brazil in October 2023, the United Kingdom and Northern Ireland in October 2023 and the United States in December 2023, WHO said in a news release on June 20
Tirzepatide should be resumed only as diet advances according to the surgical protocol and when the patient demonstrates tolerance of the prescribed diet stage without significant gastrointestinal symptoms
doi: 10.1007/s10555-020-09896-5 135 SokolovaONaumannM
The answers to these questions, and many more, are yet to be determined but will be crucial to the future of what patient access will look like for these products
Oh well, you should be fine, the doctor said
Doctors check how you react to semaglutide, track side effects, and tweak advice as needed